これは何か
Alzheimer biomarkers are biological measurements used to frame whether Alzheimer-related brain changes are present and how the disease may be staged.[1]
なぜ重要か
The 2024 criteria define Alzheimer disease biologically and incorporate core biomarkers, including imaging, CSF, and validated plasma approaches.[1]
どの判断に影響するか
解釈上の注意
- The criteria state that clinical biomarker use is presently intended for symptomatic individuals and not for cognitively unimpaired people outside research contexts.[1]